Description
Alpelisib (BYL-719) is a PI3Kα inhibitor (IC50=5 nM) with selective, potent, and oral activity, inhibiting PI3Kβ/γ/δ with low activity (IC50=250/290/1200 nM). Alpelisib demonstrates antitumor activity and specifically targets PIK3CA mutant tumors.
Molecular Formula
C19H22F3N5O2S
Smiles
CC1NC(NC(=O)N2CCC[C@H]2C(N)=O)sC1-C1CCNC(C1)C(C)(C)C(F)(F)F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 60 mg/mL (135.91 mM)10% DMSO+40% PEG300+5% Tween 80+45% Saline: 8.2 mg/mL (18.57 mM), In vivo: Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.Ethanol: 2 mg/mL (4.53 mM)